The series is stated in the current share scale after splits; dividends are not included in the price
iShares Biotechnology ETF (IBB) is an exchange-traded fund. Its exchange-traded fund shares trade on NASDAQ.
Distributions over the trailing twelve months were 0 $ per share. The fund holds equities. The annual expense ratio is 0.44%.
This summary is compiled automatically from SEC filings and exchange data.
iShares Biotechnology ETF (IBB) is an exchange-traded fund (ETF); its shares trade on Nasdaq.
iShares Biotechnology ETF trades on Nasdaq under the ticker IBB. The trading history on this page starts on 22 August 2016.
Over the past 52 weeks IBB has traded between 149.09 $ and 217.12 $. As of 2 November 2026 the price stood 79.61 % of the way from the 52-week low to the high.
Over one year IBB shares rose 34.32 %; over six months they rose 15.49 %. Volatility over 90 days is 24.16 %. Dividends are not included: this is price change only, as of 2 November 2026.
iShares Biotechnology ETF pays dividends: 0.0112 $ per share over the past twelve months, a yield of 0.01 %. The latest payment was 0.0112 $, with an ex-dividend date of 15 September 2026.
